Growth Stocks To Watch Now - April 3rd

Key Points

• MarketBeat's screener highlights five Growth stocks to watch: Prologis (PLD), Ascendis Pharma (ASND), Teledyne Technologies (TDY), Hamilton Lane (HLNE), and Tyra Biosciences (TYRA), each among the highest dollar trading volume Growth names recently.
• Prologis is a global logistics real estate leader, owning or investing in roughly 1.2 billion square feet across 19 countries, signaling large-scale exposure to e‑commerce and logistics demand.
• The list spans sectors—biotech (Ascendis, Tyra) developing endocrine and FGFR-targeted therapies, industrial/tech (Teledyne) in imaging and semiconductors, and private-market exposure via Hamilton Lane—offering growth potential but typically higher valuations and volatility.

Prologis, Ascendis Pharma A/S, Teledyne Technologies, Hamilton Lane, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenue and earnings faster than the overall market, often because of scalable business models, innovation, or expanding market share. They typically reinvest profits rather than pay dividends and trade at higher valuations, making them attractive for long-term capital appreciation but often more volatile and riskier than value or dividend stocks. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Hamilton Lane (HLNE)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Read Our Latest Research Report on HLNE

Tyra Biosciences (TYRA)

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.

Read Our Latest Research Report on TYRA

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.